Juliette Audet is the Chief Business and Strategy Officer of NewAmsterdam Pharma. She was most recently a Partner at the life science venture capital firm Forbion where she was part of the team that built NewAmsterdam Pharma. She served as a NewAmsterdam Pharma Board Member from the company's inception to her transition to the executive team.

 Before that, Juliette was a Principal at the Novartis Venture Fund, based in Cambridge, Massachusettes, and prior to this, she was a Senior Manager of Strategy at Novartis AG. Juliette spent the first part of her career in management consulting at McKinsey and Company, focusing on pharma and biotech, based out of its Swiss and New York offices. Juliette holds an MBA from Harvard Business School and an MSc in physics from Lausanne, Swiss Federal Institute of Technology.